Clinical trial
Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in…
NCT00348374 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00348374 |
|---|---|
| Title | Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes |
| Official title | A Phase 3b, Randomized, Open-Label, Parallel Group, Multicenter Trial Assessing The Efficacy Of Exubera Vs. Lispro Introduced Into A Lantus Based Regimen In Suboptimally Controlled Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Insulin Lispro, Exubera |
| Enrollment | 191 |
| Start date | Jun 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jul 4, 2006 |
| Last update posted | Mar 16, 2010 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: